Literature DB >> 10784102

A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain.

H J Gould1, T N Gould, J D England, D Paul, Z P Liu, S R Levinson.   

Abstract

Inflammation induces an upregulation of sodium channels in sensory neurons. This most likely occurs as a result of the retrograde transport of cytochemical mediators released during the inflammatory response. The purpose of this study was to determine the effect of the subcutaneous administration of one such mediator, nerve growth factor (NGF), on the production of sodium channels in neurons of the rat dorsal root ganglion. For this, hindpaw withdrawal from either a thermal or mechanical stimulus was measured in rats at selected intervals for up to 2 weeks following injections of NGF. Sodium channel augmentation was then examined in dorsal root ganglia using site-specific, anti-sodium channel antibodies. Both thermal and mechanical allodynia was observed between 3 and 12 h post-injection. The hyperalgesic response returned to baseline by approximately 24 h post-injection. Sodium channel labeling was found to increase dramatically in the small neurons of the associated dorsal root ganglia beginning at 23 h, reached maximum intensity by 1 week, and persisted for up to 3 months post-injection. Pre-blocking NGF with anti-NGF prevented the NGF-induced decrease in paw withdrawal latencies and significantly reduced the intensity of sodium channel labeling. The results indicate that NGF is an important mediator both in the development of acute hyperalgesia and in the stimulation of sodium channel production in dorsal root ganglia during inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784102     DOI: 10.1016/s0006-8993(99)02216-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

1.  Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression.

Authors:  D Y Choi; J J Toledo-Aral; R Segal; S Halegoua
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

3.  The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A.

Authors:  G Castañeda-Corral; J M Jimenez-Andrade; A P Bloom; R N Taylor; W G Mantyh; M J Kaczmarska; J R Ghilardi; P W Mantyh
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

4.  Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.

Authors:  Raimund I Herzog; Theodore R Cummins; Farshid Ghassemi; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Physiol       Date:  2003-07-03       Impact factor: 5.182

5.  Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation.

Authors:  E M Hoffman; Z Zhang; M B Anderson; R Schechter; K E Miller
Journal:  Neuroscience       Date:  2011-07-28       Impact factor: 3.590

Review 6.  Bone Pain and Muscle Weakness in Cancer Patients.

Authors:  Daniel P Milgrom; Neha L Lad; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Curr Osteoporos Rep       Date:  2017-04       Impact factor: 5.096

7.  A-kinase anchoring protein 150 expression in a specific subset of TRPV1- and CaV 1.2-positive nociceptive rat dorsal root ganglion neurons.

Authors:  Katherine E Brandao; Mark L Dell'Acqua; S Rock Levinson
Journal:  J Comp Neurol       Date:  2012-01-01       Impact factor: 3.215

Review 8.  The role of sodium channels in chronic pain.

Authors:  Simon R Levinson; Songjiang Luo; Michael A Henry
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

9.  Lidocaine prevents referred hyperalgesia associated with cystitis.

Authors:  Simone D Guerios; Zun-Yi Wang; Kyle Boldon; Wade Bushman; Dale E Bjorling
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

10.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.